Status:

COMPLETED

Stress Incontinence Trial With Elitone Device

Lead Sponsor:

Elidah, Inc.

Conditions:

Stress Urinary Incontinence

Eligibility:

FEMALE

21-75 years

Phase:

NA

Brief Summary

This is a randomized controlled study in which subjects are assigned to either a treatment group or a control (sham) group. Pre- and post-study outcome measures evaluate the change in incontinence epi...

Detailed Description

The Elitone device delivers electrical muscle stimulation to pelvic floor muscles through a disposable surface electrode shaped to fit the perineal region. In typical use women self-administer treatme...

Eligibility Criteria

Inclusion

  • Predominant Mild-moderate stress incontinence symptoms as determined by self-reported typical number of accidents of 1 per 24 hours or more.

Exclusion

  • Severe incontinence as determined by self-reported \>5 accidents in 24-hr period
  • Currently pregnant, may be pregnant, attempting to become pregnant, or delivery within previous 6 weeks
  • Implanted cardiac device, untreated cardiac arrhythmia or suffer from other heart problems.
  • Cancer, epilepsy or cognitive dysfunction
  • Vaginal or pelvic surgery within previous 6 months
  • Complete denervation of the pelvic floor
  • History or symptoms of urinary retention, extra-urethral incontinence, overflow incontinence
  • Active urinary tract infection (UTI) or history of recurrent UTIs (more than three in a year)
  • Recurrent vaginitis (bacterial/fungal)
  • Pelvic pain/painful bladder syndrome
  • Underlying neurologic/neuromuscular disorder
  • Severe Obesity as defined by BMI \>= 35
  • Chronic coughing
  • Impaired decision making, drug or alcohol dependence, or suicidal thoughts.
  • Anyone who lacks the capacity to consent for themselves or who requires a legal representative to give informed consent.

Key Trial Info

Start Date :

September 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 31 2019

Estimated Enrollment :

87 Patients enrolled

Trial Details

Trial ID

NCT03782116

Start Date

September 1 2018

End Date

March 31 2019

Last Update

January 13 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Nationwide At-Home study

Monroe, Connecticut, United States, 06468